Literature DB >> 2173787

Evidence for covalent attachment of the adeno-associated virus (AAV) rep protein to the ends of the AAV genome.

R O Snyder1, D S Im, N Muzyczka.   

Abstract

We have demonstrated that when the covalently joined ends of linear adeno-associated virus (AAV) DNA are resolved in vitro, the virus-encoded Rep protein becomes covalently attached to the 5' ends of the DNA. The covalent bond is between a tyrosine residue of the AAV Rep protein and a 5' phosphate of a thymidine residue in the AAV genome. Only the Rep protein encoded by the AAV p5 promoter, Rep68, was capable of becoming covalently attached to the ends of the AAV genome; the Rep proteins encoded by the p19 promoter were not. We also investigated some of the requirements for the complete in vitro resolution reaction. Inhibitor studies suggested that terminal resolution required DNA polymerase delta, ATP, and the deoxyribonucleoside triphosphates but did not require the remaining ribonucleoside triphosphates, DNA polymerase alpha, RNA polymerase II, or topoisomerases I and II. Finally, purified AAV Rep68, when added to the crude cytosol from uninfected HeLa cells, was sufficient for resolution. This suggested that terminal resolution relies on host enzymes and the virus-encoded p5 Rep proteins.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2173787      PMCID: PMC248795          DOI: 10.1128/JVI.64.12.6204-6213.1990

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  74 in total

Review 1.  DNA polymerase alpha.

Authors:  I R Lehman; L S Kaguni
Journal:  J Biol Chem       Date:  1989-03-15       Impact factor: 5.157

2.  A genome-linked copy of the NS-1 polypeptide is located on the outside of infectious parvovirus particles.

Authors:  S F Cotmore; P Tattersall
Journal:  J Virol       Date:  1989-09       Impact factor: 5.103

Review 3.  Mammalian DNA polymerases alpha and delta: current status in DNA replication.

Authors:  A G So; K M Downey
Journal:  Biochemistry       Date:  1988-06-28       Impact factor: 3.162

4.  Evidence for a ligation step in the DNA replication of the autonomous parvovirus minute virus of mice.

Authors:  S F Cotmore; M Gunther; P Tattersall
Journal:  J Virol       Date:  1989-02       Impact factor: 5.103

5.  Characterization of a large form of DNA polymerase delta from HeLa cells that is insensitive to proliferating cell nuclear antigen.

Authors:  J Syvaoja; S Linn
Journal:  J Biol Chem       Date:  1989-02-15       Impact factor: 5.157

6.  Calf thymus DNA polymerase delta independent of proliferating cell nuclear antigen (PCNA).

Authors:  F Focher; M Gassmann; P Hafkemeyer; E Ferrari; S Spadari; U Hübscher
Journal:  Nucleic Acids Res       Date:  1989-03-11       Impact factor: 16.971

7.  Factors that bind to adeno-associated virus terminal repeats.

Authors:  D S Im; N Muzyczka
Journal:  J Virol       Date:  1989-07       Impact factor: 5.103

8.  Helper-free stocks of recombinant adeno-associated viruses: normal integration does not require viral gene expression.

Authors:  R J Samulski; L S Chang; T Shenk
Journal:  J Virol       Date:  1989-09       Impact factor: 5.103

9.  Maturation of parvovirus LuIII in a subcellular system. II. Isolation and characterization of nucleoprotein intermediates.

Authors:  D E Muller; G Siegl
Journal:  J Gen Virol       Date:  1983-05       Impact factor: 3.891

10.  Adeno-associated virus general transduction vectors: analysis of proviral structures.

Authors:  S K McLaughlin; P Collis; P L Hermonat; N Muzyczka
Journal:  J Virol       Date:  1988-06       Impact factor: 5.103

View more
  73 in total

1.  Factors affecting the terminal resolution site endonuclease, helicase, and ATPase activities of adeno-associated virus type 2 Rep proteins.

Authors:  J Wu; M D Davis; R A Owens
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

2.  Mutational analysis of adeno-associated virus type 2 Rep68 protein endonuclease activity on partially single-stranded substrates.

Authors:  M D Davis; J Wu; R A Owens
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

3.  Mechanism of Rep-mediated adeno-associated virus origin nicking.

Authors:  J R Brister; N Muzyczka
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

4.  In vivo resolution of circular plasmids containing concatemer junction fragments from minute virus of mice DNA and their subsequent replication as linear molecules.

Authors:  S F Cotmore; P Tattersall
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

5.  High-level expression of adeno-associated virus (AAV) Rep78 or Rep68 protein is sufficient for infectious-particle formation by a rep-negative AAV mutant.

Authors:  C Hölscher; J A Kleinschmidt; A Bürkle
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

6.  Negative regulation of the adeno-associated virus (AAV) P5 promoter involves both the P5 rep binding site and the consensus ATP-binding motif of the AAV Rep68 protein.

Authors:  S R Kyöstiö; R S Wonderling; R A Owens
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

7.  The cellular TATA binding protein is required for rep-dependent replication of a minimal adeno-associated virus type 2 p5 element.

Authors:  Achille François; Mickaël Guilbaud; Rafi Awedikian; Gilliane Chadeuf; Philippe Moullier; Anna Salvetti
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

8.  Identification of linear DNA sequences that specifically bind the adeno-associated virus Rep protein.

Authors:  D M McCarty; D J Pereira; I Zolotukhin; X Zhou; J H Ryan; N Muzyczka
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

9.  Characterization of cell lines that inducibly express the adeno-associated virus Rep proteins.

Authors:  Q Yang; F Chen; J P Trempe
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

10.  Interaction of the adeno-associated virus Rep protein with a sequence within the A palindrome of the viral terminal repeat.

Authors:  D M McCarty; J H Ryan; S Zolotukhin; X Zhou; N Muzyczka
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.